RNA Stock Performance and Key Statistics

RNA has a current P/E ratio of -4.82

The RNA stock has a trailing twelve month price-to sales (P/S) ratio of 10.74 while its price-to-book (P/B) value is 0.94.

RNA's price-to-free-cashflow (P/FCF) ratio is -4.12, an indicator that is currently being trending upward.

Based on RNA's recent bid, its distance from 20 days simple moving average is 0%. It is 0.42% apart from 50 days simple moving average, and it is 38.79% apart from 200 days simple moving average.

The 52-week high for RNA is $16.77 which is -0.36% away from the current price level whereas the distance of that from the 52-week low of $11.40 stands at 238.45%.

The performance of RNA stock was not encouraging with most of its significant price indicators in green. Atrium Therapeutics, Inc.(NASDAQ: RNA) shares have moved downward -1.00% or - $0.13 in the latest trading session and have gained 0.47% year-to-date (YTD). The stock has gained nearly 156.17% over the past year. After moving 51.33% over the trailing 3-month period, the stock is 113.02% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 0.17% a week and 0.83% a month.

The current 14-day RSI for RNA stock is 57.58. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Atrium Therapeutics, Inc. (RNA) has a 14-day ATR of 0.22.

After closing at $12.94 with 17.11M of its shares outstanding, the current enterprise value of RNA is roughly 1.82B.

Atrium Therapeutics, Inc. (NASDAQ: RNA) is up 156.17% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 9.62%. RNA stock price is also up 0.47% on its value in year-to-date trading.

The number outstanding shares of RNA is 17.11M, and of these 83.81% shares are freely available for trading. On average, RNA stock has traded 220.53K shares per day for the past 10 days. A total of 236.92K shares changed hands during the last trading session with the average session volume of 326.4K shares.